COMMUNIQUÉS West-GlobeNewswire

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
23/02/2018
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference
23/02/2018
OXFORD, United Kingdom, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]
Bellicum Announces Update on Clinical Hold of U.S. BPX-501 Studies
23/02/2018
HOUSTON, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Avivagen Announces Two Year Distribution Agreement with PACC Pets and Attendance at Global Pet Expo
23/02/2018
OTTAWA, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]
Insider's tradings
23/02/2018
Nasdaq Copenhagen 23 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]
Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2017
23/02/2018
Performs within guidance for Revenue and EBITDA for 2017 MDSS service contracts divestiture completed Company continues to pay regular quarterly dividend of $0.055 cents per share SUWANEE, Ga., Feb. 23, 2018 (GLOBE [...]
HMS Holdings Corp. Reports Fourth Quarter and Full Year 2017 Results
23/02/2018
4Q GAAP EPS of $0.30 Per Diluted Share / Full Year GAAP EPS of $0.47 Per Diluted Share 4Q Adjusted EPS of $0.49 Per Diluted Share / Full Year Adjusted EPS of $1.11 Per Diluted Share Federal Tax Law Changes Resulted in [...]
Veritas Pharma Completes Share Purchase Agreement of Sechelt Organic Marijuana Corp.
23/02/2018
VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that it has completed the Share Purchase [...]
Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ
23/02/2018
Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ Paris - February 23, 2018 - Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, [...]
Sanofi : Sanofi annonce l'expiration de la période d'attente prévue par la loi Hart-Scott-Rodino pour l'acquisition de Bioverativ
23/02/2018
Sanofi annonce l'expiration de la période d'attente prévue par la loi Hart-Scott-Rodino pour l'acquisition de Bioverativ Paris - Le 23 février 2018 - Sanofi annonce aujourd'hui la fin de la période d'attente prévue par [...]
Medtech specialist Acarix AB names Christian Lindholm as Interim CEO
23/02/2018
Press release Malmö, February 23, 2018 Medtech specialist Acarix AB names Christian Lindholm as Interim CEO Acarix AB (publ) ("Acarix"), developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment [...]
Montebello to distribute Biohit products in Norway
23/02/2018
Biohit Oyj Press release, February 23rd, 2018 at 10:00 a.m. local time (EET) Biohit Oyj and Montebello Diagnostics AS have signed an agreement for the distribution of Biohit diagnostic products in Norway. The contract [...]
Aino Health AB (publ): publishes Year-end Report October - December 2017
23/02/2018
Aino Health AB (publ) has published its Year-end Report for the period, 1 October - 31 December 2017 today. It is available on the Aino Health website, see also attached pdf-document. Significant events - Business [...]
Notice for the Annual General Meeting of Novo Nordisk A/S
23/02/2018
Bagsværd, Denmark, 23 February 2018 - The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 22 March 2018 at 2.00 pm (CET) at Royal Arena, entrance G, Hannemanns Allé 20, 2300 Copenhagen S, Denmark. [...]
FDA Accepts Shire's BLA and Grants Priority Review for Lanadelumab for the Prevention of Attacks in HAE Patients
23/02/2018
FDA Accepts Shire's Biologics License Application (BLA) and Grants Priority Review for Lanadelumab for the Prevention of Attacks in Hereditary Angioedema (HAE) Patients - Lanadelumab, the first long-acting [...]
Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract
23/02/2018
Basel, Switzerland, February 23, 2018 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has commenced enrollment in the first of its two planned clinical phase 3 registration studies of the antibiotic [...]
Addex Publishes Extraordinary General Meeting Invitation
23/02/2018
Geneva, Switzerland, 23 February 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that it has published the Invitation to its [...]
Dova Pharmaceuticals, Inc. Announces Pricing of Offering of Common Stock
23/02/2018
DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is [...]
Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018
22/02/2018
MEDFORD, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for [...]

Pages